Cargando…
Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio
Eliminating the risk of polio from vaccine-derived polioviruses is essential for creating a polio-free world, and eliminating that risk will require stopping use of all oral polio vaccines (OPVs) once all types of wild polioviruses have been eradicated. In many ways, the experience with the global s...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853572/ https://www.ncbi.nlm.nih.gov/pubmed/28838193 http://dx.doi.org/10.1093/infdis/jix105 |
_version_ | 1783306777236865024 |
---|---|
author | Hampton, Lee M. du Châtellier, Gaël Maufras Fournier-Caruana, Jacqueline Ottosen, Ann Rubin, Jennifer Menning, Lisa Farrell, Margaret Shendale, Stephanie Patel, Manish |
author_facet | Hampton, Lee M. du Châtellier, Gaël Maufras Fournier-Caruana, Jacqueline Ottosen, Ann Rubin, Jennifer Menning, Lisa Farrell, Margaret Shendale, Stephanie Patel, Manish |
author_sort | Hampton, Lee M. |
collection | PubMed |
description | Eliminating the risk of polio from vaccine-derived polioviruses is essential for creating a polio-free world, and eliminating that risk will require stopping use of all oral polio vaccines (OPVs) once all types of wild polioviruses have been eradicated. In many ways, the experience with the global switch from trivalent OPV (tOPV) to bivalent OPV (bOPV) can inform the eventual full global withdrawal of OPV. Significant preparation will be needed for a thorough, synchronized, and full withdrawal of OPV, and such preparation would be aided by setting a reasonably firm date for OPV withdrawal as far in advance as possible, ideally at least 24 months. A shorter lead time would provide valuable flexibility for decisions about when to stop use of OPV in the context of uncertainty about whether or not all types of wild polioviruses had been eradicated, but it might increase the cost of OPV withdrawal. |
format | Online Article Text |
id | pubmed-5853572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-58535722018-07-01 Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio Hampton, Lee M. du Châtellier, Gaël Maufras Fournier-Caruana, Jacqueline Ottosen, Ann Rubin, Jennifer Menning, Lisa Farrell, Margaret Shendale, Stephanie Patel, Manish J Infect Dis Supplement Article Eliminating the risk of polio from vaccine-derived polioviruses is essential for creating a polio-free world, and eliminating that risk will require stopping use of all oral polio vaccines (OPVs) once all types of wild polioviruses have been eradicated. In many ways, the experience with the global switch from trivalent OPV (tOPV) to bivalent OPV (bOPV) can inform the eventual full global withdrawal of OPV. Significant preparation will be needed for a thorough, synchronized, and full withdrawal of OPV, and such preparation would be aided by setting a reasonably firm date for OPV withdrawal as far in advance as possible, ideally at least 24 months. A shorter lead time would provide valuable flexibility for decisions about when to stop use of OPV in the context of uncertainty about whether or not all types of wild polioviruses had been eradicated, but it might increase the cost of OPV withdrawal. Oxford University Press 2017-07-01 2017-07-01 /pmc/articles/PMC5853572/ /pubmed/28838193 http://dx.doi.org/10.1093/infdis/jix105 Text en © The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by/3.0/igo/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 IGO (CC BY 3.0 IGO) License (https://creativecommons.org/licenses/by/3.0/igo/) which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Article Hampton, Lee M. du Châtellier, Gaël Maufras Fournier-Caruana, Jacqueline Ottosen, Ann Rubin, Jennifer Menning, Lisa Farrell, Margaret Shendale, Stephanie Patel, Manish Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio |
title | Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio |
title_full | Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio |
title_fullStr | Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio |
title_full_unstemmed | Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio |
title_short | Considerations for the Full Global Withdrawal of Oral Polio Vaccine After Eradication of Polio |
title_sort | considerations for the full global withdrawal of oral polio vaccine after eradication of polio |
topic | Supplement Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853572/ https://www.ncbi.nlm.nih.gov/pubmed/28838193 http://dx.doi.org/10.1093/infdis/jix105 |
work_keys_str_mv | AT hamptonleem considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio AT duchatelliergaelmaufras considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio AT fourniercaruanajacqueline considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio AT ottosenann considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio AT rubinjennifer considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio AT menninglisa considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio AT farrellmargaret considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio AT shendalestephanie considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio AT patelmanish considerationsforthefullglobalwithdrawaloforalpoliovaccineaftereradicationofpolio |